Top Page
Cranswick
(LSE:CWK)
Cranswick (CWK) vs. iShares MSCI United Kingdom ETF (EWC)
Cranswick Business Overview & Revenue Model
Cranswick Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.72B | 2.72B | 2.60B | 2.32B | 2.01B | 1.90B |
| Gross Profit | 419.90M | 408.80M | 376.90M | 295.70M | 276.80M | 265.70M |
| EBITDA | 275.70M | 280.70M | 253.60M | 220.00M | 199.00M | 185.50M |
| Net Income | 134.30M | 134.30M | 113.10M | 111.40M | 103.50M | 92.50M |
Balance Sheet | ||||||
| Total Assets | 1.53B | 1.53B | 1.38B | 1.26B | 1.14B | 1.04B |
| Cash, Cash Equivalents and Short-Term Investments | 5.90M | 5.90M | 27.00M | 20.40M | 200.00K | 39.90M |
| Total Debt | 178.30M | 178.30M | 127.40M | 121.70M | 106.20M | 131.40M |
| Total Liabilities | 543.30M | 543.30M | 472.50M | 421.50M | 373.60M | 355.00M |
| Stockholders Equity | 987.90M | 987.90M | 911.50M | 842.90M | 768.90M | 686.10M |
Cash Flow | ||||||
| Free Cash Flow | 78.70M | 78.70M | 127.90M | 64.10M | 64.70M | 109.00M |
| Operating Cash Flow | 216.30M | 216.30M | 228.40M | 149.20M | 158.40M | 180.90M |
| Investing Cash Flow | -160.40M | -160.40M | -123.30M | -83.80M | -130.90M | -81.80M |
| Financing Cash Flow | -77.00M | -77.00M | -93.40M | -45.30M | -66.30M | -81.60M |
Cranswick Technical Analysis
Cranswick Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £1.11B | 21.05 | 12.12% | 0.78% | 0.49% | 14.18% | |
75 Outperform | £1.40B | 24.74 | 9.10% | 2.45% | 4.03% | 3.21% | |
73 Outperform | £2.82B | 21.18 | 14.14% | 1.93% | 4.77% | 18.94% | |
71 Outperform | £752.17M | 19.17 | 12.74% | 4.12% | -0.03% | 7.88% | |
71 Outperform | £1.66B | 13.26 | 9.02% | 1.45% | 1.01% | 11.12% | |
69 Neutral | £2.39B | 38.81 | 3.39% | 3.67% | 5.40% | -67.46% | |
63 Neutral | $20.46B | 14.47 | -3.60% | 3.13% | 2.63% | -6.18% |
Cranswick Corporate Events
Cranswick plc has announced that as of August 1, 2025, the total number of ordinary shares in its capital is 54,264,605, with each share granting one voting right. This figure is crucial for shareholders to determine their notification requirements under the Financial Conduct Authority’s Disclosure and Transparency Rules.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc announced that all resolutions proposed at its 2025 Annual General Meeting were successfully passed, with most receiving significant majorities. However, the resolution concerning the Directors’ Remuneration Report received less than 80% approval, prompting the Board to continue engaging with shareholders to address their concerns. This engagement reflects Cranswick’s commitment to aligning with shareholder expectations and adhering to the UK Corporate Governance Code.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick reported strong trading in the first quarter of the financial year, with a 9.7% increase in revenue compared to the previous year, driven by new business wins and strong demand for premium products. The acquisition of Blakemans contributed positively, and export revenue was bolstered by the reinstatement of the Norfolk pork site’s China export license. The company is accelerating capital expenditure to enhance capacity and efficiency, with significant investment in the Lincoln Pet Products site. Cranswick also refinanced its banking facility, securing a £360 million revolving credit facility to support future growth.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc announced a transaction involving the sale of 4,000 ordinary shares by Christie Brisby, the spouse of Director James Robert Brisby, on the London Stock Exchange. This transaction, disclosed as part of regulatory requirements, may impact the company’s stock dynamics and reflects internal managerial activities, potentially influencing stakeholder perceptions.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc announced that Director Christopher Aldersley has acquired ordinary shares as ‘Partnership Shares’ under the Cranswick 2024 Buy As You Earn Share Incentive Plan. This acquisition, part of a regular monthly purchase program, also involved the awarding of ‘Matching Shares.’ The transaction, conducted on the London Stock Exchange, reflects the company’s ongoing commitment to aligning the interests of its management with those of its shareholders, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick PLC, a UK-based company, has announced a change in its major holdings as BlackRock, Inc. has increased its voting rights in the company. BlackRock’s voting rights have risen to 5.36% from a previous 5.00%, indicating a strategic move that could influence Cranswick’s future decisions and shareholder dynamics.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc has announced a transaction involving the purchase of ordinary shares by Yetunde Hofmann, a director of the company. This transaction, conducted on the London Stock Exchange, reflects internal confidence in the company’s market position and future prospects, potentially influencing stakeholder perceptions positively.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc has announced the total number of ordinary shares in its capital as of July 7, 2025, amounting to 54,262,862, with each share granting one vote. This information is crucial for shareholders to calculate their interests or changes in interests in the company’s share capital under the Financial Conduct Authority’s Disclosure and Transparency Rules.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc, a company involved in the food production sector, announced that four of its directors have exercised and sold share options as part of the company’s Long Term Incentive Plan and Company Share Option Scheme. The directors, Chris Aldersley, Mark Bottomley, Jim Brisby, and Adam Couch, sold portions of their shares at an average price of 5218.3 pence per share. According to the company’s remuneration policy, the remaining vested shares are to be held for two years. This transaction, conducted on the London Stock Exchange, is part of routine financial activities and reflects the directors’ engagement with the company’s incentive schemes.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc has disclosed a transaction involving Christie Brisby, the spouse of Director James Robert Brisby, who transferred ordinary shares to him as part of financial planning. This transaction, involving 3,675 shares at a price of 1,800 pence each, was conducted outside a trading venue on June 26, 2025, and reflects internal financial management strategies within the company’s leadership.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc announced a transaction involving James Robert Brisby, a director of the company, who transferred ordinary shares from his spouse, Christie Brisby, as part of financial planning. The transaction involved 3,675 shares at a price of 1,800 pence each and took place on June 26, 2025, outside a trading venue. This disclosure highlights the company’s commitment to transparency in its managerial transactions, which could impact stakeholders’ perception of governance and financial planning strategies.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc has released its Annual Report and Financial Statements for 2025 and announced the details of its upcoming Annual General Meeting, scheduled for 28 July 2025. The documents are accessible on the company’s website and through the National Storage Mechanism, reflecting Cranswick’s commitment to transparency and regulatory compliance.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc announced that Director Christopher Aldersley acquired ordinary shares as ‘Partnership Shares’ under the company’s 2024 Buy As You Earn Share Incentive Plan. This acquisition is part of a regular monthly purchase program, reflecting the company’s ongoing commitment to align management interests with those of shareholders, potentially enhancing stakeholder confidence in the company’s governance and strategic direction.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc announced a transaction involving John Mark Bottomley, a director of the company, who transferred ordinary shares into an ISA. The transaction, conducted on the London Stock Exchange, involved the sale and purchase of shares at 5300 pence each, with a slight difference in volume between the sale and purchase. This notification highlights the ongoing financial activities and transparency within the company’s managerial operations.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc announced a transaction involving the transfer of ordinary shares by Tracy Bottomley, the spouse of Director John Mark Bottomley, into an Individual Savings Account (ISA). The transaction, conducted on the London Stock Exchange, involved the sale and purchase of shares at a price of 5300 pence each, with minimal volume difference. This notification underscores the company’s commitment to transparency in financial dealings by its managerial personnel.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc has announced the grant of Long Term Incentive Plan (LTIP) awards to its executive directors. The awards, which are based on a share price of 5290 pence per ordinary share, consist of both Core LTIP Awards and Exceptional Performance LTIP Awards. The vesting of these awards is contingent upon meeting specific performance criteria related to Earnings per Share (EPS), Return on Capital Employed (ROCE), and Total Shareholder Return (TSR). This initiative underscores Cranswick’s commitment to aligning executive incentives with shareholder interests and enhancing company performance.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc has announced the total number of ordinary shares in its capital as of May 30, 2025, which stands at 54,252,023. Each share carries one vote, and with no shares held in treasury, the total number of voting rights is also 54,252,023. This figure is crucial for shareholders to determine their interest or changes in the share capital under the Financial Conduct Authority’s Disclosure and Transparency Rules.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick PLC has announced a change in its shareholder structure, with BlackRock, Inc. crossing a 5% threshold in voting rights as of May 23, 2025. This development indicates a significant shift in the company’s ownership dynamics, potentially impacting its strategic direction and stakeholder interests.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc announced that Director Christopher Aldersley acquired ordinary shares as ‘Partnership Shares’ under the company’s 2024 Buy As You Earn Share Incentive Plan. This transaction, conducted on the London Stock Exchange, is part of a regular monthly purchase program, reflecting the company’s commitment to aligning management interests with shareholder value.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick plc announced its preliminary results for the 52 weeks ending March 2025, reporting a 4.8% increase in revenue to £2,723.3 million and a 12.1% rise in adjusted profit before tax to £197.9 million. The company highlighted strong growth in its premium product range, with significant contributions from its agricultural operations and strategic acquisitions, such as JSR Genetics and Blakemans. The company also reported a record capital investment of £138 million aimed at expanding capacity and enhancing operational efficiencies. These results underscore Cranswick’s robust market positioning and commitment to long-term growth, benefiting stakeholders through increased dividends and strategic partnerships.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.
Cranswick PLC, a UK-based company, announced a change in its shareholder structure as BlackRock, Inc., a major asset management firm, has adjusted its voting rights in the company. The notification indicates that BlackRock’s voting rights in Cranswick have fallen below 5%, which could impact the company’s governance and influence in strategic decisions. This adjustment in holdings might affect stakeholders’ perceptions and the company’s market positioning.
The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.